Even successful tuberculosis treatment may not fully restore health prospects, challenging assumptions about infectious disease recovery. The Brazilian cohort data suggests TB creates lasting physiological vulnerabilities that persist long after bacterial clearance. Analysis of 100 million health records reveals tuberculosis survivors face elevated mortality risks across multiple organ systems—not just respiratory complications. Cardiovascular deaths increased significantly, along with cancer, endocrine disorders, and ongoing lung disease. The excess mortality spans years beyond treatment completion, indicating TB may accelerate biological aging or compromise immune surveillance permanently. This finding reframes tuberculosis from an acute infectious episode to a chronic health condition with systemic consequences. The sheer scale of this Brazilian dataset—representing nearly half the country's population—provides unprecedented statistical power to detect long-term patterns invisible in smaller studies. Previous TB research focused primarily on treatment success rates and immediate outcomes, missing these delayed mortality signals. The cardiovascular and cancer connections are particularly striking, suggesting TB infection may trigger inflammatory cascades or cellular damage that persists despite antibiotic therapy. For the 10 million people diagnosed with tuberculosis annually worldwide, this research implies the need for extended health monitoring and preventive care strategies. The findings also raise questions about current treatment protocols—whether longer courses, adjunct therapies, or post-treatment interventions might better restore normal life expectancy. This represents a paradigm shift from viewing TB as curable to recognizing it as a disease requiring lifelong health vigilance.